Skip to content
Menu

Piper Sandler Upgrades Medtronic to Overweight, Raises Price Target to $120

Benzinga Newsdesk 5 days ago

Analyst RatingsNewsUpgradesPrice TargetHot

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Piper Sandler analyst Matt O'Brien upgrades Medtronic (NYSE:MDT) from Neutral to Overweight and raises the price target from $85 to $120.

Piper Sandler analyst Matt O'Brien upgrades Medtronic (NYSE:MDT) from Neutral to Overweight and raises the price target from $85 to $120.

Read at benzinga.com

← All stock news